← back to search

Longfeng Jiang

Infectious Disease Consultants · US
Area of research
Hepatology · Epidemiology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Hepatitis C virus research, Liver Disease and Transplantation, and Drug-Induced Hepatotoxicity and Protection.
h-index
17
citations
1,175
works
59
NIH funding
primary concept
email

Recent publications

Noninvasive Quantification of Hepatic Steatosis Using Ultrasound‐Derived Fat Fraction (CHESS2303): A Prospective Multicenter Study
MedComm 2025cited by 16position: middledoi
The Foxo1-YAP-Notch1 axis reprograms STING-mediated innate immunity in NASH progression
Experimental & Molecular Medicine 2024cited by 24position: middledoi
The macrophage STING-YAP axis controls hepatic steatosis by promoting the autophagic degradation of lipid droplets
Hepatology 2023cited by 45position: middledoi
Macrophage PTEN controls STING-induced inflammation and necroptosis through NICD/NRF2 signaling in APAP-induced liver injury
Cell Communication and Signaling 2023cited by 42position: lastdoi
Macrophage RIPK3 triggers inflammation and cell death via the XBP1–Foxo1 axis in liver ischaemia–reperfusion injury
JHEP Reports 2023cited by 22position: middledoi
Novel role of macrophage TXNIP-mediated CYLD–NRF2–OASL1 axis in stress-induced liver inflammation and cell death
JHEP Reports 2022cited by 63position: middledoi
The Dual Role of Innate Immune Response in Acetaminophen-Induced Liver Injury
Biology 2022cited by 40position: lastdoi
Functional crosstalk between myeloid Foxo1–β-catenin axis and Hedgehog/Gli1 signaling in oxidative stress response
Cell Death and Differentiation 2020cited by 90position: middledoi
Loss of ATF3 exacerbates liver damage through the activation of mTOR/p70S6K/ HIF-1α signaling pathway in liver inflammatory injury
Cell Death and Disease 2018cited by 69position: middledoi
Genetic Variants in Human Leukocyte Antigen-DP Influence Both Hepatitis C Virus Persistence and Hepatitis C Virus F Protein Generation in the Chinese Han Population
International Journal of Molecular Sciences 2014cited by 14position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Bibo Ke · UCLA Medical Center6 papers (2018–2024)Douglas G. Farmer · UCLA Medical Center5 papers (2020–2024)Dongwei Xu · Mudanjiang Medical University5 papers (2020–2024)Xiao Wang · 81th Hospital of PLA5 papers (2022–2024)Tao Yang · Guiyang College of Traditional Chinese Medicine5 papers (2022–2024)Mingwei Sheng · Tianjin First Center Hospital4 papers (2020–2024)Yuanbang Lin · Tianjin Medical University General Hospital4 papers (2020–2024)Qiang Xia · Zunyi Medical University4 papers (2022–2024)Yizhu Tian · Zhejiang International Studies University3 papers (2020–2024)Yongqiang Zhan · University of California, Los Angeles3 papers (2020–2024)Michael Ke · University of California, Los Angeles3 papers (2022–2024)Changyong Li · Tianjin University3 papers (2018–2024)Xiaoye Qu · Renji Hospital3 papers (2022–2023)X. B. Qu · MEI Technologies (United States)2 papers (2023–2024)Jun Li · Ministry of Education of the People's Republic of China2 papers (2022–2023)Jun Li · Qinghai University2 papers (2023–2023)Han Wang · Huazhong University of Science and Technology2 papers (2018–2022)Jerzy W. Kupiec‐Weglinski · Riverside Transplantation Institute1 papers (2020–2020)Yuting Jin · Nanjing University of Chinese Medicine1 papers (2024–2024)Bin Jiang · Nanjing University of Chinese Medicine1 papers (2018–2018)